INOVIO Pharmaceuticals
NEWS ALERT

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Press Releases

INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense

Posted on November 16, 2020

INOVIO Reports Third Quarter 2020 Financial Results

Posted on November 9, 2020

INOVIO to Report Third Quarter 2020 Financial Results on November 9, 2020

Posted on October 26, 2020

INOVIO Reports FDA Partial Clinical Hold for Planned Phase 2 / 3 Trial of COVID-19 Vaccine Candidate INO-4800

Posted on September 28, 2020

INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium

Posted on September 8, 2020

INOVIO to Present at Upcoming Investor Conferences in September

Posted on September 1, 2020

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.